Adult Incontinence Products Wholesale for Europe Market



Europe is the world's largest and most mature adult incontinence market, driven by a rapidly aging population, high healthcare standards, and strong consumer awareness. For distributors and private label brands, the European market offers stable demand, premium pricing, and significant growth potential. This guide covers the European adult incontinence market in detail.

European Adult Incontinence Market Overview

The European adult incontinence products market was valued at approximately $4.5 billion in 2025, growing at 4-6% annually. Key drivers include:

• Rapidly aging population: Europe has the oldest population in the world. By 2030, over 25% of Europeans will be 65+. Incontinence prevalence increases sharply with age: 15% at age 65, 30% at age 75, 50% at age 85+.
• High awareness and acceptance: Unlike many Asian or Middle Eastern markets, incontinence is openly discussed in Europe. Consumers are willing to seek medical advice and purchase specialized products rather than using baby diapers or makeshift solutions.
• Healthcare reimbursement: In many European countries, incontinence products are partially or fully reimbursed by national health systems or insurance. This ensures consistent demand and reduces price sensitivity.
• Preference for pull up style: European consumers strongly prefer pull up style (protective underwear) over tape-style diapers for community-dwelling users, because they are more discreet and easier to use independently.
• Eco-friendly trend: European consumers are increasingly concerned about environmental impact. Biodegradable, compostable, and plastic-free incontinence products are a fast-growing niche.

Country-by-Country Market Analysis

Germany: The Largest European Market

Germany is the largest adult incontinence market in Europe, with 84 million people and 18 million aged 65+.

• Market size: $1.1 billion (2025), growing 4-5% annually
• Key players: Essity (Tena, the global leader with ~40% market share), Paul Hartmann (Molicare), Ontex (iD), Domtar (Attends), Kimberly-Clark (Depend)
• Consumer preference: Quality and performance-driven. German consumers are very brand-loyal to Tena but are open to private label alternatives with comparable quality. Pull up style dominates (60%+). Heavy and overnight absorbency levels have strong demand due to the elderly population.
• Popular sizes: M, L, XL. L is the top seller. XL demand is growing due to larger body types and bariatric care.
• Distribution: Pharmacy (Apotheke) is the primary channel for prescription/reimbursed products. Drugstores (Rossmann, dm, Müller) for retail. Medical supply stores (Sanitätshaus) for institutional and heavy care. Online pharmacies (Shop-Apotheke, DocMorris) growing fast.
• Regulatory: CE marking mandatory under MDR (Medical Device Regulation) 2017/745. Class I medical device. German packaging law (VerpackG) requires packaging registration and recycling compliance. BAT (Bundesausschuss für Arzneimittel und Medizinprodukte) approval for reimbursement.

United Kingdom: Second Largest, Strong Retail Channel

The UK has 67 million people, 12 million aged 65+, and a strong retail-driven incontinence market.

• Market size: $750 million (2025), growing 4-6% annually
• Key players: Essity (Tena), Kimberly-Clark (Depend), Ontex (iD), Domtar (Attends), supermarket private labels (Sainsbury's, Boots, Tesco)
• Consumer preference: More price-sensitive than Germany. Supermarket private labels have significant market share (25%+). Pull up style dominant. Discreetness is a key buying factor for active users.
• Popular sizes: M, L, XL. L is top seller.
• Distribution: Supermarkets (Tesco, Sainsbury's, Asda) and pharmacies (Boots, Lloyds) dominate retail. NHS prescription for eligible patients. Online (Amazon UK, Tena Direct, incontinence specialists) growing fast.
• Regulatory: UKCA marking (post-Brexit) or CE marking accepted. MHRA (Medicines and Healthcare products Regulatory Agency) registration. UK Packaging Waste Regulations. NHS framework approval for institutional sales.

France: Strong Pharmacy Channel

France has 68 million people, 14 million aged 65+, and a pharmacy-dominated healthcare market.

• Market size: $650 million (2025), growing 4-5% annually
• Key players: Essity (Tena), Ontex (iD), Paul Hartmann (Molicare), Domtar (Attends), Laboratoire CCD
• Consumer preference: Quality and comfort-driven. French consumers prefer soft, skin-friendly products. Strong preference for unscented products. Pull up style growing but tape-style still significant for institutional use.
• Popular sizes: M, L, XL.
• Distribution: Pharmacy (Pharmacie) is the dominant retail channel (60%+). Medical supply stores (Magasin médical) for institutional. Online pharmacies growing. Supermarkets carry limited range.
• Regulatory: CE marking under MDR. ANSM (Agence nationale de sécurité du médicament) registration. French packaging law (AGEC - Anti-Waste for a Circular Economy) requires plastic reduction and recycling labeling.

Italy, Spain, and Other European Markets

• Italy: $450 million market, 59 million people. Pharmacy-dominated. Strong preference for Tena and private labels. CE marking + Italian Ministry of Health registration. Aging population in Northern Italy drives demand.
• Spain: $400 million market, 48 million people. Pharmacy and parapharmacy channels. More price-sensitive than Northern Europe. Mercadona and other supermarkets growing private label. CE marking + AEMPS registration.
• Netherlands/Belgium: $250 million combined. High healthcare standards, strong reimbursement systems. Pharmacy and medical supply channels. Dutch consumers are early adopters of eco-friendly products.
• Nordics (Sweden, Norway, Denmark, Finland): $300 million combined. Highest per capita spending on incontinence products. Strong reimbursement systems. Eco-friendly and sustainable products are mainstream expectations. Essity (Swedish company) dominates.
• Poland/Central Europe: $200 million and growing fast (8-10% annually). Lower penetration but catching up. More price-sensitive. Pharmacy and retail channels growing. CE marking required.

Consumer Preferences in the European Market

European incontinence consumers have distinct preferences that differentiate the market from other regions:

Product Features That Matter Most

1. Discreetness: European users want products that are thin, quiet, and not visible under clothing. Pull up style is preferred because it looks and feels like regular underwear. Bulkiness is a major complaint.
2. Skin health: Adult skin is more fragile than baby skin. European consumers prioritize breathable backsheets, soft top sheets, pH-balanced materials, and lotion-treated surfaces (aloe vera, vitamin E) to prevent incontinence-associated dermatitis (IAD).
3. Odor control: Odor is a major concern for active users. Products with effective odor control (activated carbon, baking soda, odor-locking technology) command a premium. Scented products are less popular; unscented with odor neutralization is preferred.
4. Leakage protection: Dual leg cuffs, standing gathers, and extra-long core are expected features. European consumers are intolerant of leakage and will switch brands quickly if leakage occurs.
5. Easy removal: Tear-away side seams are standard and expected. They should tear easily but not tear during normal wear.
6. Wetness indicator: Standard on most products, helps caregivers know when to change.

Absorbency Level Preferences

• Light/moderate (daytime): 40-45% of market. For active users with mild to moderate incontinence. Thin, discreet products.
• Heavy/maximum: 35-40% of market. For moderate to heavy incontinence, longer wear time. Fastest growing segment as population ages.
• Overnight/extra heavy: 15-20% of market. For nighttime use and heavy care. Highest margin segment.
• Booster pads: A growing niche product used inside pull ups or diapers to add extra absorbency without changing the outer product.

CE Marking and MDR Regulatory Requirements

Adult incontinence products sold in Europe must comply with the Medical Device Regulation (MDR) 2017/745, which replaced the old MDD (Medical Devices Directive) in May 2021.

Classification

Adult pull up diapers and incontinence products are classified as Class I medical devices (lowest risk class). This means:

• Self-certification is allowed (no Notified Body assessment required for standard Class I products)
• The manufacturer must declare conformity and affix the CE mark
• Technical documentation must be maintained and available for 10 years after the last product is placed on the market

Key MDR Requirements

1. Technical documentation: Must include product description, intended use, risk analysis (ISO 14971), design and manufacturing information, biological safety evaluation (ISO 10993), clinical evaluation, labeling and instructions for use, and post-market surveillance plan.
2. Biocompatibility testing: Products in prolonged skin contact must meet ISO 10993-1 (biological evaluation), including cytotoxicity, sensitization, and irritation testing. Test reports from ISO 17025 accredited laboratories are required.
3. EU Authorized Representative: Non-EU manufacturers (e.g., China factories) must appoint an EU Authorized Representative (AR) located in the EU. The AR is responsible for ensuring compliance and acting as the contact point for EU authorities.
4. EUDAMED registration: Manufacturers and products must be registered in EUDAMED (the EU database for medical devices). The UDI (Unique Device Identification) system is being phased in; Class I devices must comply by 2025-2027.
5. Post-market surveillance: Manufacturers must monitor product performance after launch, report adverse events (vigilance), and conduct periodic safety updates.
6. Labeling requirements: CE mark, manufacturer name/address, EU AR name/address, intended use, size, absorbency level, lot number, production date, expiry date, storage instructions, and "single use" symbol. Instructions for use must be in the language of the destination country.

Packaging and Environmental Regulations

Europe has some of the world's strictest packaging and environmental regulations:

• Germany (VerpackG): All packaging must be registered with LUCID (Central Packaging Register). Producers must participate in a dual system (e.g., Der Grüne Punkt, Duales System Deutschland) and pay recycling fees based on packaging material and weight.
• France (AGEC): Requires anti-waste and circular economy labeling. The "Triman" logo must appear on all recyclable packaging. Plastic packaging is being phased out for certain applications.
• EU Packaging and Packaging Waste Regulation (PPWR): New EU-wide regulation (entering into force 2025-2030) requiring all packaging to be recyclable by 2030, minimum recycled content in plastic packaging, and reduced packaging weight.
• REACH: Chemicals used in products (including adhesives, inks, lotions) must comply with REACH (Registration, Evaluation, Authorization and Restriction of Chemicals). Certain substances (e.g., phthalates, formaldehyde) are restricted or banned.

Distribution Channels in Europe

Channel	Market Share	Key Players	Margin Structure
Pharmacy	35-40%	Independent pharmacies, pharmacy chains (Boots, DocMorris)	Distributor 20-25%, Pharmacy 30-40%
Retail/Drugstore	20-25%	Rossmann, dm, Müller, Tesco, Sainsbury's, Mercadona	Distributor 15-20%, Retail 25-35%
Medical Supply / Institutional	20-25%	Sanitätshaus (DE), Magasin médical (FR), care homes, hospitals	Distributor 15-20%, Institution 20-30%
Online / E-commerce	10-15%	Amazon, online pharmacies, brand direct, incontinence specialists	Distributor 15-20%, Platform 10-15%
Other (direct, catalog)	5-10%	Direct sales, mail order, subscription services	Higher direct margin (30-40%)

Private Label Opportunities in Europe

Private label adult incontinence products have significant growth potential in Europe:

• Current private label share: 15-20% of the total market, varying by country. Higher in the UK (25%+) and Spain (20%+), lower in Germany (10-15%) where Tena brand loyalty is strong.
• Growth drivers: (1) Retailers seeking higher margins than branded products; (2) Consumers becoming more open to private label as quality improves; (3) Healthcare systems seeking cost savings through generic products; (4) Online channels making it easier for new brands to reach consumers.
• Key success factors for private label: (1) Quality must be comparable to Tena/Molicare, not inferior; (2) Competitive pricing at 20-30% below branded products; (3) Professional packaging with clear absorbency and size information; (4) CE marking and full MDR compliance; (5) Reliable supply with consistent quality.
• Target customers for private label: (1) Retail chains and supermarkets looking for store brand products; (2) Pharmacy chains and buying groups; (3) Medical supply distributors and institutional buyers; (4) Online retailers and subscription services; (5) Healthcare providers and insurance companies seeking cost-effective products.

Sourcing Adult Incontinence Products from China for Europe

China is a competitive sourcing base for European private label buyers, but compliance is critical:

• MDR-compliant factories: Look for factories with ISO 13485 certification (medical device quality management system) and experience exporting to Europe. The factory must be able to provide technical documentation, biological safety test reports (ISO 10993), and CE declaration of conformity.
• EU Authorized Representative: The factory or you (as the importer) must appoint an EU Authorized Representative. Many China factories already have an EU AR; if not, you can appoint one independently (cost: €500-€2,000 per year).
• Raw material compliance: All materials must comply with REACH. The factory should provide REACH declarations of compliance for all components, including adhesives, inks, elastics, and lotions.
• Packaging compliance: Packaging must meet country-specific recycling regulations. The factory should be able to provide packaging material weight declarations for LUCID (Germany) and Triman labeling (France).
• Quality consistency: European customers have high quality expectations. Implement strict incoming material inspection, in-process quality control, and pre-shipment inspection. Consider third-party inspection (SGS, BV) for each shipment, especially for the first 3-5 orders.
• Lead time: Production lead time for adult pull up diapers is 25-35 days from order confirmation to shipment. Ocean freight from China to Europe takes 30-40 days. Total door-to-door time: 60-80 days. Plan inventory accordingly.

Recommended Market Entry Strategy

1. Choose your entry country: The UK is often the best entry point for new private label brands because of strong retail private label acceptance, English language, and straightforward regulatory process (UKCA or CE). Germany offers the largest market but has stronger brand loyalty and higher quality expectations. Poland/Central Europe offers fast growth and lower competition.
2. Start with pull up style, M and L sizes: Pull up is the dominant and fastest-growing format. M and L cover 60-70% of the market. Add XL in the second order. Start with heavy absorbency (the fastest-growing segment) and daytime absorbency.
3. Focus on quality, not just price: European consumers will not accept inferior quality. Position your private label as "comparable quality to leading brands at 20-30% lower price." Invest in premium features: breathable backsheet, soft top sheet, odor control, aloe lotion, wetness indicator.
4. Get MDR compliance right from day one: CE marking, technical documentation, EU AR, EUDAMED registration, REACH compliance. Non-compliance can result in product seizure, fines, and being banned from the EU market. Budget €3,000-€8,000 for initial compliance setup.
5. Target pharmacy and medical supply channels first: These channels have higher margins and are more open to private label than mass retail. Build a customer base in these channels before approaching large retail chains.
6. Consider eco-friendly positioning: European consumers are increasingly concerned about the environment. If you can offer products with reduced plastic, biodegradable components, or recyclable packaging, you can differentiate your brand and command a premium. This is a strong trend in Nordic countries and the Netherlands.

Conclusion

Europe is the world's largest and most mature adult incontinence market, offering stable demand, premium pricing, and significant private label growth potential. The key to success is understanding country-specific market dynamics, meeting strict MDR regulatory requirements, offering quality comparable to leading brands at competitive prices, and choosing the right distribution channels. With a rapidly aging population and growing acceptance of private label products, the European market offers excellent long-term opportunities for distributors and brand owners who source quality products from compliant China factories.

Fujian New Yifa Group manufactures MDR-compliant adult pull up diapers for the European market with ISO 13485 certification, full technical documentation, and REACH-compliant materials. The factory offers private label production in all sizes and absorbency levels and supports EU Authorized Representative coordination. Learn more about adult pull up diaper OEM in our complete OEM manufacturing guide.

Frequently Asked Questions

Which European country is best for entering the adult incontinence market?

The UK is often the best entry point for new private label brands because of strong retail private label acceptance (25%+ market share), English language, straightforward regulatory process (UKCA or CE marking accepted), and a large online retail channel. Germany offers the largest market ($1.1 billion) but has stronger brand loyalty to Tena and higher quality expectations. Poland and Central Europe offer the fastest growth (8-10% annually) and lower competition, but at lower price points.

What are the CE marking requirements for adult diapers sold in Europe?

Adult incontinence products are classified as Class I medical devices under the MDR (Medical Device Regulation) 2017/745. Requirements include: (1) Technical documentation covering product description, risk analysis (ISO 14971), biological safety (ISO 10993), and clinical evaluation; (2) EU Authorized Representative for non-EU manufacturers; (3) EUDAMED registration; (4) Post-market surveillance system; (5) CE marking on product and packaging with required labeling (manufacturer info, AR info, size, absorbency, lot number, expiry). Class I devices can be self-certified without Notified Body assessment, but the technical documentation must be complete and available for 10 years.

What is the typical profit margin for adult incontinence product distributors in Europe?

Distributor margins in the European adult incontinence market typically range from 15-25%, depending on the channel. Pharmacy and medical supply channels offer higher margins (20-25%) because products are often reimbursed and less price-sensitive. Retail and drugstore channels offer lower margins (15-20%) due to higher competition and price pressure. Private label products can offer 5-10% higher margins than branded products because there is no brand royalty and the distributor controls pricing. Institutional and online direct sales can offer even higher margins (25-35%).

How important is eco-friendly packaging for the European market?

Eco-friendly packaging is increasingly important in Europe and is becoming a regulatory requirement rather than just a marketing preference. Germany's VerpackG requires packaging registration and recycling fee payment. France's AGEC requires Triman labeling and plastic reduction. The new EU PPWR (Packaging and Packaging Waste Regulation) will require all packaging to be recyclable by 2030 with minimum recycled content. Beyond regulation, Nordic consumers and Dutch/German consumers actively seek out eco-friendly products and are willing to pay a 10-15% premium for sustainable options. For private label brands, eco-friendly positioning is a strong differentiator.

What is the minimum order quantity for private label adult incontinence products for Europe?

Most China factories require 100,000-200,000 pieces per size for private label OEM orders. For a European market entry, we recommend starting with 2 sizes (M and L) x 2 absorbency levels (daytime and heavy) = 4 SKUs, at 50,000-100,000 pieces each, totaling 200,000-400,000 pieces (2-3 containers). This gives you enough product variety to test the market while meeting factory MOQ requirements. For the first order, budget €50,000-€100,000 for product cost plus €3,000-€8,000 for regulatory compliance setup (EU AR, technical documentation, EUDAMED registration).